Endothelial disfunction and its markers at hestosis

Abstract

There is review of the literature and the own data of the authors shown the of endothelins, endothelial-relaxing of the factor, factor of tumor necrosis, factor Willebrand, tissiue of a catalyst plasminogen, endotheliocites in patigenesis gestosis. These markers endothelial disfunction have large value in diagnostics and control of efficiency of therapy of hestosis.

Keywords

markers of endothelial dysfunction / the role of endothelin / endothelium-relaxing factor / tumor necrosis / von Willebrand factor / tissue plasminogen activator / endothelial cells in the pathogenesis of gestosis

References

[1] Айламазян Э. К. Антиоксиданты в комплексной терапии позднего токсикоза беременных и связанной с ним хронической гипоксии плода // Акуш. и гинекол.-1991.-№3 -С. 30-33.

[2] Айламазян Э.К., Тарасова М.А. Иммунологические методы прогнозирования и диагностики позднего токсикоза беременных //Акуш. и гинекол.-1986.-№6 -С.39-41.

[3] Зазерская И.Е. Определение функциональной и метаболической активности тромбоцитов при позднем токсикозе//Автореф. дис... к.м.н.-Л., 1991 -С. 21.

[4] Петрищев Н.Н. Тромборезистентность сосудов. - СПб, "АНТ-М", 1994 -С. 130.

[5] Репина М.А., Конычева Е.А. Состояние гемостаза у беременных с гестозом // Актуальные вопросы службы крови и трансфузиологии. —СПб, 1995-С. 157-159.

[6] Торопова Б.Г., Горностаев В.С., Данилов О. А., Нягулов Д.Ф. и др. Иммуноферментный анализ фактора Виллебранда с использованием моноклональных антител.// Лаб. дело. -1990-№10- С. 52-55.

[7] Arbogast B.W., Leeper S.С., Merrick R. D. et al. Which plasma factors bringth about disturbance of endotelial function in preeclampsia?// Lancet. -1994-Vol. 343-P.3400-341.

[8] Bowry S. K., Prentice C. R. M., Courtney J. M. A modification of the Wu and Hoak method for the determination of platelet aggregates and platelet adhesion // Thromb. Haemost. -1985.—Vol. 53,№3.-P. 381-385.

[9] Caron C., Goudeman J., Marey A., Beage D. et al. Are haemostatic and fibrinolytic parametres predictors of preeclampsia in pregnancy-associated hypertension? // Thromb. Haemost. — 1991.-Vol.66, № 4.—P.4KM14.

[10] Davis J. W., Shehon L., Eigenberg D.A., Hignite C.E. et al. Effects of tobacco and nontobacco cigarette smoking on endothelium and platelete // Clin. PharmacoL Ther.-1985.-Vol.37. -P. 529-533.

[11] De Jager C.A., Shephard E.G., Robson S.C., Jaskiewicz K. et al. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia //J. Lab. Clin. Med.-1995.-Vol. 125. -№- 4. -P. 522-530.

[12] Delacretaz E., de Quay N., Waeber B., Vial Y. et al. Differential nitric oxide synthese activity in human platelets during normal pregnancy and preeclampsia // Clin. Sci. CoIch. — 1995.-Vol.88.-№ 6.-P. 607-610.

[13] Dulitzki M., Pauzner R., Langevitz P., Pras M. et al. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies // Obstet. Gynecol.-1996.- Vol. 87. -№ 3. -P. 380-383.

[14] Friedman S. A. Preeclampsia: a review of the role of prostaglandins // Obstet. Gynecol. -1988. - Vol. 71.-P. 122-137.

[15] Friedman S.A., Lubarsky S.L., Ahokas R.A., Nova A. Preeclampsia and related disorders. Clinical aspects and relevance of endothelin and nitric oxide //Clin. Perinatol. -1995.-Vol.22. - № 2. - P. 343-355.

[16] Foumier A., Fievet P., el Esper I., el Esper N. et al. Hypertension et grossesse. Diagnostic, physiopathologie et traitment//Schweiz. Med. Wochenschr.-1995.-Vol.125.-№ 47. -P. 2273-2298.

[17] Furuhashi N., Kimura H., Nagae H., Yajima A. Maternal plasma endothelin levels and fetal status in normal and preeclamptic pregnancies // Gynecol. Obstet. Invest.-1995.-Vol.39.-N. 2 -P.88-92.

[18] Ghabour M.S., Eis A. L, Brockman D.E., Pollock J.S. et al. Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia // Am. J. Obstet. Gynecol.-1995.-Vol. 173. -№3-P. 687-694.

[19] Gillis S., Shushan A., Elder A. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy // Int. J. Gynaecol. Obstet.-1992.- Vol.39.-№4.-P. 297-301.

[20] Greer I.A., Leask R., Hodson B.A, Daves J. et al. Endothelin, elastase and endothelial disfunction in preeclampsia // Lancet.-1991 -Vol. 337. -P.558.

[21] Hladovec J., Rossmann P. Circulating endothelial cells isolated together with platelets and the experimental modification of their count in rats // Thromb. Res.-1973.-Vol.3-P. 663-674.

[22] Ignarro L.J. Physiological significansc of nitric oxide // Semin. Perinatal.-1991.-Vol. 15. -P. 20-26.

[23] Melissari E., Parker C.J., Wilson N. V., Monte G. et al. Use of low molecular weight heparin in pregnancy //Thromb. Haemost.-1992.-Vol. 68. -№ 6.-P.652-656.

[24] Pinto A., Sorrentmo R., Sorrentino P. et al. Endothelial derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension // Am. J. Obstet. Gynecol.-1991. -Vol. 164 -P. 507-513.

[25] Sabry S., Mondon P., Levy M, Ferre F. et al. Endothelial modulation of vasoconstrictor responses to endothelin-l in human placental stem villi small arteries // Br. J. Pharmacol.-1995.-Vol. 115.-№ 6-P. 1038-1042.

[26] Sarrel P.M., Lindsay D.C., Poole- Wilson P.A. et al. Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of preeclampsia // Lancet. -1990.-Vol. 336.-P. 1030-1032.

[27] Sinzinger H., Virgolini L, Fitscha P., Rauscha F. et al. Stabilization of endothelial lining and decrease in circulating endothelial cells one mechanism underlying the clinical action of PGEl // Br. J. Clin. Pharmacol.-1988.-Vol. 25. -P. 775-776.

[28] Tomobe Y., Miyauchi T., Saito A., Yanagisawa M. et al. Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats // Europ. J. PharmacoL.- 1988.-Vol. 152. -№ 3. -P. 373-374. Vinatier D., Prolongeau J.F., Dufour P., Tordjeman N.

[29] Physiopathologie de la preeclampsie: place de l'immunologie //J. Gynecol. Obstet. Biol. Reprod. Paris.-1995.-Vol. 24. -№ 4-P. 387-399.

[30] Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia // Br. Y. Obstet. Gynaecol.-1995.- Vol. 102.—№ I. -P. 20-25.

RIGHTS & PERMISSIONS

Eсо-Vector